GAMMA Investing’s Coherus Oncology CHRS Stock Holding History

GAMMA Investing’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.24K	Sell	885 -325	-27%	-$531	﹤0.01%	3827
2026 Q1	$2.04K	Buy	1,210 +803	+197%	+$1.43K	﹤0.01%	3660
2025 Q4	$578	Buy	+407	New	+$593	﹤0.01%	3894
2024 Q4	–	Sell	-1,788	Closed	-$1.86K	–	3789
2024 Q3	$1.86K	Hold	1,788	–	–	﹤0.01%	3094
2024 Q2	$3.09K	Hold	1,788	–	–	﹤0.01%	2742
2024 Q1	$4.27K	Sell	1,788 -294	-14%	-$723	﹤0.01%	2471
2023 Q4	$4.48K	Buy	+2,082	New	+$5.58K	﹤0.01%	2290

Other funds holding CHRS

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.8B AUM 48.92% 1-Year Est. Return

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return